These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16499119)

  • 1. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 2. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
    Raffa RB; Duong PV; Finney J; Garber DA; Lam LM; Mathew SS; Patel NN; Plaskett KC; Shah M; Jen Weng HF
    J Clin Pharm Ther; 2006 Apr; 31(2):129-38. PubMed ID: 16635046
    [No Abstract]   [Full Text] [Related]  

  • 6. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice.
    Johnston MF; Yang C; Hui KK; Xiao B; Li XS; Rusiewicz A
    Integr Cancer Ther; 2007 Mar; 6(1):36-41. PubMed ID: 17351025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.
    Maruff P; Falleti MG; Collie A
    Cancer; 2004 Nov; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
    Weis J; Poppelreuter M; Bartsch HH
    Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy for primary breast cancer: facts versus anecdotes.
    Hortobagyi GN
    J Clin Oncol; 1999 Nov; 17(11 Suppl):25-9. PubMed ID: 10630258
    [No Abstract]   [Full Text] [Related]  

  • 13. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.
    Stewart A; Collins B; Mackenzie J; Tomiak E; Verma S; Bielajew C
    Psychooncology; 2008 Feb; 17(2):122-30. PubMed ID: 17518411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
    Paraska K; Bender CM
    Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.
    Stewart A; Bielajew C; Collins B; Parkinson M; Tomiak E
    Clin Neuropsychol; 2006 Feb; 20(1):76-89. PubMed ID: 16410227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).
    Grunfeld E; Dhesy-Thind S; Levine M;
    CMAJ; 2005 May; 172(10):1319-20. PubMed ID: 15883407
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-dense chemotherapy for breast cancer: the story so far.
    Hudis C
    Br J Cancer; 2000 Jun; 82(12):1897-9. PubMed ID: 10864194
    [No Abstract]   [Full Text] [Related]  

  • 19. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB; van Dam FS
    J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
    Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.